glaxosmithkline plc-spon adr
(GSKN:Mexico)
GSKN
Industry Average
Profitability - glaxosmithkline plc-spon adr (GSKN)
|
Return on Assets Industry Comparison
10.83%
|
Return on Equity Industry Comparison
51.18%
|
|
|
Return on Capital Industry Comparison
17.69%
|
Margin Analysis - glaxosmithkline plc-spon adr (GSKN)
|
Gross Margin Industry Comparison
70.52%
|
Levered Free Cash Flow Margin Industry Comparison
13.48%
|
|
|
EBITDA Margin Industry Comparison
34.32%
|
SG&A Margin Industry Comparison
29.77%
|
Asset Turnover - glaxosmithkline plc-spon adr (GSKN)
|
Total Assets Turnover Industry Comparison
0.6x
|
Accounts Receivables Turnover Industry Comparison
4.6x
|
|
|
Fixed Assets Turnover Industry Comparison
3.0x
|
Inventory Turnover Industry Comparison
1.9x
|
Credit Ratios - glaxosmithkline plc-spon adr (GSKN)
|
Current Ratio Industry Comparison
1.2x
|
Quick Ratio Industry Comparison
0.8x
|
Long-Term Solvency - glaxosmithkline plc-spon adr (GSKN)
|
Total Debt/Equity Industry Comparison
253.7x
|
Total Liabilities/Total Assets Industry Comparison
82.2x
|
Growth Over Prior Year - glaxosmithkline plc-spon adr (GSKN)
|
Total Revenue Industry Comparison
-4.30%
|
Tangible Book Value Industry Comparison
230.06%
|
|
|
EBITDA Industry Comparison
-7.72%
|
Gross Profit Industry Comparison
-6.94%
|
|
|
Receivables Industry Comparison
-1.37%
|
Inventory Industry Comparison
4.72%
|
|
|
Diluted EPS Before Extra Industry Comparison
-14.51%
|
Capital Expenditures Industry Comparison
22.05%
|
|
|
Cash From Ops. Industry Comparison
-26.53%
|
Levered Free Cash Flow Industry Comparison
-15.90%
|
| Recently Viewed | |||
| GSKN:MM | $646.30 MXN | 0.00 |  |
| Company | Last | Change |
| 3M Co | $110.52 USD | -0.27 |
| Bayer AG | €83.82 EUR | -1.42 |
| Gilead Sciences Inc | $55.93 USD | 0.00 |
| Merck & Co Inc | $47.14 USD | +0.43 |
| Sanofi | €84.81 EUR | -1.62 |
| View Industry Companies | ||
Industry Analysis
GSKN
Industry Average
| Valuation | GSKN | Industry Range |
| Price/Earnings | 20.7x |
|
| Price/Sales | 3.3x |
|
| Price/Book | 12.8x |
|
| Price/Cash Flow | 20.6x |
|
| TEV/Sales | 3.3x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
